HSP90AB1 and neoplasm: A number of studies shown that Hsp90 inhibitors decreased the expression of VEGFR-1, inhibited the migration and tube formation of endothelial cell to further inhibit tumor angiogenesis in various cancers such as colorectal adenocarcinoma [50].